Researchers still don’t know how well BA.2.86 will evade immunity or whether it will cause more severe disease than its predecessors.
Academic rigour, journalistic flair
Articles on BA.2
Displaying all articles
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
It’s hard to keep up. But new Omicron sub-variants are emerging that may lead to reinfections and another spike in cases.
Instead of minimizing current or future waves of COVID-19, we need strategies to deal with new variants efficiently. Only then can we live with the virus in a healthy way.
The latest addition to the omicron lineage has been making waves in Europe. Whether it will do the same in the U.S. depends on rates of vaccination and prior infection.
Top contributors
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Professor, Biology, York University, Canada
-
Australian Research Council Future Fellow, The University of Melbourne
-
Research fellow, CSIRO
-
Assistant Professor of Infectious Diseases, University of Virginia
